Expanding global access to oncology trials: mCODE-aligned AI for inclusive patient matching across literacy and resource settings. - ASCO https://t.co/7zQVWU18P5
Bispecific Antibodies in Hematologic Malignancies in the Outpatient and Community Settings - Gonugunta - 2026 - Advances in Hematology - Wiley Online Library https://t.co/PMPPdmO3Fm
Unsupervised risk factor identification across cancer types and data modalities via explainable artificial intelligence | npj Digital Medicine https://t.co/FGpDFSPkNk
Genomic mechanisms of resistance to venetoclax in multiple myeloma with t(11;14)(CCND1;IGH) | Blood | American Society of Hematology https://t.co/bp3U3eQaI7
Multimodal framework for the joint analysis of single-cell RNA and T cell receptor sequencing data predicts T cell response to cancer immunotherapy | Nature Communications https://t.co/bIVDl74tGY